DE69032599D1 - Gegengifte und verfahren zu deren herstellung - Google Patents
Gegengifte und verfahren zu deren herstellungInfo
- Publication number
- DE69032599D1 DE69032599D1 DE69032599T DE69032599T DE69032599D1 DE 69032599 D1 DE69032599 D1 DE 69032599D1 DE 69032599 T DE69032599 T DE 69032599T DE 69032599 T DE69032599 T DE 69032599T DE 69032599 D1 DE69032599 D1 DE 69032599D1
- Authority
- DE
- Germany
- Prior art keywords
- venoms
- whole
- antivenom
- atrox
- durissus terrificus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002435 venom Substances 0.000 abstract 7
- 210000001048 venom Anatomy 0.000 abstract 7
- 231100000611 venom Toxicity 0.000 abstract 7
- 230000002303 anti-venom Effects 0.000 abstract 5
- 241000271537 Crotalus atrox Species 0.000 abstract 2
- 241000271533 Crotalus durissus terrificus Species 0.000 abstract 2
- 229920000936 Agarose Polymers 0.000 abstract 1
- 241000271566 Aves Species 0.000 abstract 1
- 241000271511 Bothrops atrox Species 0.000 abstract 1
- 241000271527 Crotalus adamanteus Species 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 241000270295 Serpentes Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 239000003083 cnidarian venom Substances 0.000 abstract 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000002795 scorpion venom Substances 0.000 abstract 1
- 239000003998 snake venom Substances 0.000 abstract 1
- 239000002708 spider venom Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
- C07K17/08—Peptides being immobilised on, or in, an organic carrier the carrier being a synthetic polymer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/804—Drug, bio-affecting and body treating compositions involving IgG3, IgG4, IgA, or IgY
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/824—Immunological separation techniques
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
- Y10S530/813—Carrier is a saccharide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/855—Proteins from animals other than mammals or birds
- Y10S530/856—Snakes; venom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/855—Proteins from animals other than mammals or birds
- Y10S530/858—Proteins from animals other than mammals or birds insects; venom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/861—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgG3, IgG4, IgA, or IgY
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/429,791 US5196193A (en) | 1989-10-31 | 1989-10-31 | Antivenoms and methods for making antivenoms |
PCT/US1990/006341 WO1991006306A1 (en) | 1989-10-31 | 1990-10-31 | Antivenoms and methods for making antivenoms |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69032599D1 true DE69032599D1 (de) | 1998-10-01 |
Family
ID=23704763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69032599T Expired - Lifetime DE69032599D1 (de) | 1989-10-31 | 1990-10-31 | Gegengifte und verfahren zu deren herstellung |
Country Status (5)
Country | Link |
---|---|
US (4) | US5196193A (de) |
EP (1) | EP0498854B1 (de) |
AT (1) | ATE170079T1 (de) |
DE (1) | DE69032599D1 (de) |
WO (1) | WO1991006306A1 (de) |
Families Citing this family (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5196193A (en) * | 1989-10-31 | 1993-03-23 | Ophidian Pharmaceuticals, Inc. | Antivenoms and methods for making antivenoms |
US5599539A (en) * | 1989-10-31 | 1997-02-04 | Ophidian Pharmaceuticals, Inc. | Therapy for clostridial botulinum toxin |
US5719267A (en) * | 1989-10-31 | 1998-02-17 | Ophidian Pharmaceuticals Inc. | Clostridial toxin disease therapy |
US5736139A (en) | 1989-10-31 | 1998-04-07 | Ochidian Pharmaceuticals, Inc. | Treatment of Clostridium difficile induced disease |
US5601823A (en) * | 1989-10-31 | 1997-02-11 | Ophidian Pharmaceuticals, Inc. | Avian antitoxins to clostridium difficle toxin A |
US5919665A (en) * | 1989-10-31 | 1999-07-06 | Ophidian Pharmaceuticals, Inc. | Vaccine for clostridium botulinum neurotoxin |
US5342830A (en) * | 1990-11-16 | 1994-08-30 | Cor Therapeutics, Inc. | Antithrombosis agents |
GB9109478D0 (en) * | 1991-05-02 | 1991-06-26 | Therapeutic Antibodies Inc | Antivenoms |
US5605691A (en) * | 1992-09-17 | 1997-02-25 | Ophidian Pharmaceuticals, Inc. | Immunologically active proteins from inclusion bodies |
US7227010B2 (en) * | 1993-09-21 | 2007-06-05 | United States Of America As Represented By The Secretary Of The Army | Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy |
US7037680B2 (en) | 1993-09-21 | 2006-05-02 | The United States Of America As Represented By The Secretary Of The Army | Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy |
US7214787B1 (en) * | 1993-09-21 | 2007-05-08 | United States Of America As Represented By The Secretary Of The Army | Recombinant vaccine against botulinum neurotoxin |
GB9410871D0 (en) | 1994-05-31 | 1994-07-20 | Imperial College | Modification of tetanus toxin for use as a transport protein |
CA2191754C (en) * | 1994-05-31 | 2000-12-12 | James Oliver Dolly | Modification of clostridial toxins for use as transport proteins |
ATE366312T1 (de) | 1994-10-24 | 2007-07-15 | Ophidian Pharm Inc | Impfstoff und antitoxine zur behandlung und vorbeugung von c. difficile krankheiten |
US6967088B1 (en) * | 1995-03-16 | 2005-11-22 | Allergan, Inc. | Soluble recombinant botulinum toxin proteins |
US6037060A (en) * | 1996-11-04 | 2000-03-14 | The Boeing Company | Sol for bonding expoxies to aluminum or titanium alloys |
US5869141A (en) * | 1996-11-04 | 1999-02-09 | The Boeing Company | Surface pretreatment for sol coating of metals |
US5814137A (en) * | 1996-11-04 | 1998-09-29 | The Boeing Company | Sol for coating metals |
US5958578A (en) * | 1996-11-04 | 1999-09-28 | The Boeing Company | Hybrid laminate having improved metal-to-resin adhesion |
US5849110A (en) * | 1996-11-04 | 1998-12-15 | The Boeing Company | Sol coating of metals |
IL123001A (en) * | 1998-01-20 | 1998-12-06 | Shulov Inst For Venom Research | Analgesic fraction from snake March and pharmacy preparations containing it |
US7534866B2 (en) * | 2005-10-19 | 2009-05-19 | Ibc Pharmaceuticals, Inc. | Methods and compositions for generating bioactive assemblies of increased complexity and uses |
US7241443B1 (en) | 1999-07-15 | 2007-07-10 | Camas Incorporated | Immunogen adherence inhibitor and method of making and using same |
US7238351B2 (en) * | 1999-07-15 | 2007-07-03 | Peter Nash | Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it |
US6673346B1 (en) * | 1999-08-31 | 2004-01-06 | The Regents Of The University Of Michigan | Compositions and methods for the treatment of sepsis |
US20080038274A1 (en) * | 1999-09-23 | 2008-02-14 | Foster Keith A | Inhibition of secretion from non-neuronal cells |
DE19961141A1 (de) * | 1999-12-17 | 2001-07-26 | Mack Gerd R | Pharmazeutische Zusammensetzung aus Spinnengiften sowie deren Herstellung und Verwendung zur Behandlung von Tumorerkrankungen |
DE10024383B4 (de) * | 2000-05-17 | 2005-07-21 | Mack, Gerd R. | Mit toxischen Substanzen beladene dendritische Zellen |
US6608172B1 (en) | 2000-06-09 | 2003-08-19 | Good Biotech Corporation | Isolation of IgY (ΔFc) antibodies |
US8173783B2 (en) * | 2000-12-08 | 2012-05-08 | Good Biotech Corporation | Process for selectively isolating IgY antibodies from egg yolk of an anseriform bird and IgY antibodies obtained thereby |
US6680376B2 (en) * | 2000-12-08 | 2004-01-20 | Good Biotech Corporation | Process for selectively isolating avian immunoglobulins |
US6709655B2 (en) * | 2001-02-28 | 2004-03-23 | Instituto Bioclon, S.A. De C.V. | Pharmaceutical composition of F(ab1)2 antibody fragments and a process for the preparation thereof |
US20030211330A1 (en) * | 2002-05-09 | 2003-11-13 | Anderson Robert A. | Method of preparing a metal material for bonding |
US20040076630A1 (en) * | 2002-09-18 | 2004-04-22 | Maurine Pearson | Method for creating antigens using Emus |
US20100003253A1 (en) * | 2002-11-08 | 2010-01-07 | Ablynx N.V. | Single domain antibodies directed against epidermal growth factor receptor and uses therefor |
PT2316852E (pt) * | 2002-11-08 | 2014-06-23 | Ablynx Nv | Anticorpos de domínio único estáveis |
US9320792B2 (en) | 2002-11-08 | 2016-04-26 | Ablynx N.V. | Pulmonary administration of immunoglobulin single variable domains and constructs thereof |
US20060034845A1 (en) * | 2002-11-08 | 2006-02-16 | Karen Silence | Single domain antibodies directed against tumor necrosis factor alpha and uses therefor |
NZ540194A (en) * | 2002-11-08 | 2008-07-31 | Ablynx Nv | Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
US7335759B2 (en) * | 2002-12-02 | 2008-02-26 | Universidad Nacional Autónoma de Méxica (UNAM) | Recombinant immunogens for the generation of antivenoms to the venom of scorpions of the genus Centruroides |
US9701737B2 (en) | 2003-02-19 | 2017-07-11 | Camas, Incorporated | Immunogen adherence and method of making and using same |
MXPA03003959A (es) * | 2003-03-18 | 2004-09-23 | Invest Aplic S A De C V | Uso de inmunoglobulinas procedentes de yema de huevo, para el tratamiento de infecciones causados por parasitos, tanto en animales como en el humano. |
NZ543498A (en) * | 2003-05-14 | 2007-06-29 | Immunogen Inc | A conjugate comprising an antibody chemically coupled to a maytansinoid |
WO2005009464A1 (en) * | 2003-07-25 | 2005-02-03 | Lopez De Silanes Juan | Administration of anti-cytokine f(ab')2 antibody fragments |
US20070258986A1 (en) * | 2003-11-19 | 2007-11-08 | Govt of the US as represented by the secretary, | Targeted Delivery System for Bioactive Agents |
AU2003290419A1 (en) * | 2003-12-31 | 2005-07-21 | Council Of Scientific And Industrial Research | A process for preparing egg yolk antibodies |
US9481878B2 (en) | 2004-02-13 | 2016-11-01 | Immunomedics, Inc. | Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity |
US8491914B2 (en) * | 2004-02-13 | 2013-07-23 | Ibc Pharmaceuticals, Inc. | Dock-and-lock (DNL) complexes for delivery of interference RNA |
US8551480B2 (en) * | 2004-02-13 | 2013-10-08 | Immunomedics, Inc. | Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity |
US8173797B2 (en) * | 2004-07-21 | 2012-05-08 | Cornell Research Foundation, Inc. | Therapeutic compounds derived from spider venom and their method of use |
MXPA04008435A (es) | 2004-08-31 | 2006-03-02 | Univ Mexico Nacional Autonoma | Inmunogeno y anti-veneno contra el veneno de la arana violinista. |
DE102004055891B4 (de) * | 2004-11-19 | 2007-08-30 | Wiesner, Henning, Prof., Dr. | Gemische von Schlangengiften zur Krankheitsbekämpfung |
US9623115B2 (en) * | 2005-04-06 | 2017-04-18 | Ibc Pharmaceuticals, Inc. | Dock-and-Lock (DNL) Complexes for Disease Therapy |
US7381802B2 (en) * | 2005-04-15 | 2008-06-03 | Universidad Nacional Autónoma De México (UNAM) | Human antibodies that specifically recognize the toxin Cn2 from Centruroides noxius scorpion venom |
US7767789B2 (en) * | 2005-06-02 | 2010-08-03 | University Hopitals of Cleveland | Truncated proteins as cancer markers |
EP1917030A4 (de) * | 2005-08-03 | 2011-03-09 | Immunogen Inc | Immunkonjugatformulierungen |
US7927828B2 (en) * | 2005-10-17 | 2011-04-19 | Spidertech, a division of Stoecker & associates, LLC | Immunoassay for venom detection including noninvasive sample collection |
JP2007172129A (ja) * | 2005-12-20 | 2007-07-05 | Sony Corp | 不揮発性メモリアクセス制御装置および不揮発性メモリ制御システム |
US20070231320A1 (en) * | 2006-04-03 | 2007-10-04 | Cook Mark E | Eggs having increased antibody titer and methods for making same |
ES2398412T3 (es) * | 2006-10-18 | 2013-03-19 | Biomerieux | Procedimiento de diagnóstico in vitro de cepas de Staphylococcus aureus productoras de PVL |
US20080226653A1 (en) * | 2006-10-20 | 2008-09-18 | The University Of Manitoba | Inhibition of Platelet Aggregation |
US8865169B2 (en) * | 2007-02-20 | 2014-10-21 | Tufts University | Methods and systems for multi-antibody therapies |
US9023352B2 (en) | 2007-02-20 | 2015-05-05 | Tufts University | Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding protein |
US8349326B2 (en) * | 2007-02-20 | 2013-01-08 | Tufts University | Methods and systems for multi-antibody therapies |
SG189769A1 (en) * | 2008-01-03 | 2013-05-31 | Scripps Research Inst | Antibody targeting through a modular recognition domain |
US8557242B2 (en) | 2008-01-03 | 2013-10-15 | The Scripps Research Institute | ERBB2 antibodies comprising modular recognition domains |
US8454960B2 (en) | 2008-01-03 | 2013-06-04 | The Scripps Research Institute | Multispecific antibody targeting and multivalency through modular recognition domains |
US8574577B2 (en) | 2008-01-03 | 2013-11-05 | The Scripps Research Institute | VEGF antibodies comprising modular recognition domains |
US8557243B2 (en) | 2008-01-03 | 2013-10-15 | The Scripps Research Institute | EFGR antibodies comprising modular recognition domains |
TNSN08110A1 (en) * | 2008-03-11 | 2009-07-14 | Rekik Raouf Dr | Drug delivery to the anterior and posterior segment of the eye from drops |
JP5522405B2 (ja) * | 2008-04-25 | 2014-06-18 | 協和発酵キリン株式会社 | 安定な多価抗体 |
US20100087455A1 (en) * | 2008-10-06 | 2010-04-08 | Auspex Pharmaceuticals, Inc. | Substituted xanthine compounds |
WO2010051635A1 (en) * | 2008-11-06 | 2010-05-14 | University Of Guelph | Methods of improving the therapeutic efficacy and utility of antibody fragments |
US20110311515A1 (en) * | 2009-01-14 | 2011-12-22 | Ablynx N.V. | Pulmonary administration of immunoglobulin single variable domains and constructs thereof |
EP2230515B1 (de) * | 2009-03-16 | 2014-12-17 | Agilent Technologies, Inc. | Passivierung von Oberflächen nach Ligandenkupplung |
US20120064064A1 (en) * | 2009-05-28 | 2012-03-15 | Thil Dinuk Batuwangala | Antigen-binding proteins |
IN2012DN03025A (de) * | 2009-09-09 | 2015-07-31 | Ct Se Llc | |
EP2563817B1 (de) | 2010-04-30 | 2021-09-22 | UNM Rainforest Innovations | Fluoreszente fusionspolypeptide und verwendungsverfahren dafür |
BR112012028315A2 (pt) | 2010-05-07 | 2016-10-25 | Camas Inc | "composição, borrifo oral, borrifo nasal, tira oral, enxaguatório bucal, e, método para prevenir ou reduzir a incidência de doença". |
US20120100166A1 (en) | 2010-07-15 | 2012-04-26 | Zyngenia, Inc. | Ang-2 Binding Complexes and Uses Thereof |
IT1402503B1 (it) * | 2010-07-22 | 2013-09-13 | Satanassi | Antidoto per morso di serpenti velenosi |
EP2635298B1 (de) * | 2010-11-02 | 2019-01-02 | Asellus Limited | Skorpion-gegengift zur behandlung von krebs |
EP2714738B1 (de) | 2011-05-24 | 2018-10-10 | Zyngenia, Inc. | Multivalente und monovalente multispezifische komplexe und ihre verwendungen |
WO2012177653A2 (en) * | 2011-06-20 | 2012-12-27 | St. Louis University | Targeting the neuromuscular junction for treatment |
US8926980B2 (en) | 2011-07-11 | 2015-01-06 | Camas Incorporated | Compositions against bacterial toxins |
EA038918B1 (ru) | 2013-03-15 | 2021-11-09 | Зинджения, Инк. | Пептид, связывающий рецептор эпидермального фактора роста, мультиспецифические комплексы, содержащие пептид и антитела, и их применение |
CN107429075B (zh) | 2014-11-17 | 2022-11-01 | 卡内基梅隆大学 | 可激活的双组份光敏剂 |
MA40998A (fr) | 2014-11-21 | 2017-09-26 | Ophirex Inc | Thérapies contre une envenimation, ainsi que compositions, systèmes et kits pharmaceutiques associés |
US11208841B2 (en) * | 2017-07-14 | 2021-12-28 | Hunter Douglas Inc. | Slats with an improved route hole configuration for use within a covering and related manufacturing methods |
WO2019023674A1 (en) * | 2017-07-28 | 2019-01-31 | Mccabe James G | MULTIPURPOSE VENOUS VACCINES |
US11446367B2 (en) * | 2017-07-28 | 2022-09-20 | Zootoxins, Llc | Immunization with polyvalent venom vaccines |
CN111620947B (zh) * | 2020-06-11 | 2022-05-10 | 海南热带海洋学院 | 一种二价抗海蛇毒血清的制备方法 |
CN113214391B (zh) * | 2020-12-30 | 2022-07-01 | 中国人民解放军海军军医大学 | 抗水母毒素纳米抗体koto54、制备方法及用途 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL286954A (de) * | 1962-01-03 | |||
US3616229A (en) * | 1968-09-27 | 1971-10-26 | Monsanto Co | Polymer-enzyme products comprising plurality of enzymes covalently bound to polymer |
GB1392181A (en) * | 1971-04-16 | 1975-04-30 | Rech Et Dapplications Soc Gen | Fixation of nitrogenous materials |
US4165370A (en) * | 1976-05-21 | 1979-08-21 | Coval M L | Injectable gamma globulin |
CH626917A5 (de) * | 1976-08-17 | 1981-12-15 | Pentapharm Ag | |
US4550019A (en) * | 1978-03-22 | 1985-10-29 | South Africa Inventions Development Corporation | Manufacture and use of fowl egg antibodies |
US4357272A (en) * | 1978-03-22 | 1982-11-02 | The South African Inventions Development Corporation | Recovering purified antibodies from egg yolk |
DE2951412A1 (de) * | 1979-12-20 | 1981-07-16 | South African Inventions Development Corp., Pretoria, Transvaal | Verfahren zur herstellung immunologisch reaktiver praeparate |
US4419132A (en) * | 1982-01-06 | 1983-12-06 | American Newspaper Publishers Association | Printing ink |
US4748018A (en) * | 1984-02-07 | 1988-05-31 | Stolle Research & Development Corp. | Method of passive immunization of mammals using avian antibody |
GB8321009D0 (en) * | 1983-08-04 | 1983-09-07 | New R R C | Immunological compositions |
US4849352A (en) * | 1984-10-09 | 1989-07-18 | Sullivan John B | Antibody purification process |
US4806346A (en) * | 1986-12-16 | 1989-02-21 | American Home Products Corporation | Method for isolation of antigen specific immunoglobulin |
US5196193A (en) * | 1989-10-31 | 1993-03-23 | Ophidian Pharmaceuticals, Inc. | Antivenoms and methods for making antivenoms |
-
1989
- 1989-10-31 US US07/429,791 patent/US5196193A/en not_active Expired - Lifetime
-
1990
- 1990-10-31 EP EP91900530A patent/EP0498854B1/de not_active Expired - Lifetime
- 1990-10-31 WO PCT/US1990/006341 patent/WO1991006306A1/en active IP Right Grant
- 1990-10-31 DE DE69032599T patent/DE69032599D1/de not_active Expired - Lifetime
- 1990-10-31 AT AT91900530T patent/ATE170079T1/de not_active IP Right Cessation
-
1992
- 1992-11-17 US US07/977,583 patent/US5340923A/en not_active Expired - Lifetime
-
1994
- 1994-07-14 US US08/275,304 patent/US5443976A/en not_active Expired - Lifetime
-
1995
- 1995-05-16 US US08/442,000 patent/US5904922A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5196193A (en) | 1993-03-23 |
EP0498854B1 (de) | 1998-08-26 |
EP0498854A1 (de) | 1992-08-19 |
US5443976A (en) | 1995-08-22 |
WO1991006306A1 (en) | 1991-05-16 |
EP0498854A4 (en) | 1993-03-03 |
US5340923A (en) | 1994-08-23 |
AU638786B2 (en) | 1993-07-08 |
US5904922A (en) | 1999-05-18 |
AU6895191A (en) | 1991-05-31 |
ATE170079T1 (de) | 1998-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69032599D1 (de) | Gegengifte und verfahren zu deren herstellung | |
DE68919466D1 (de) | Verfahren zur Herstellung von schraubenförmigen, glasfaserverstärkten Befestigungselementen. | |
DE3780384T2 (de) | Verfahren und system fuer biologische behandlung mit periodischer belueftung. | |
DE68923419D1 (de) | Methode zur Züchtung von Bakterien. | |
DE3863170D1 (de) | Mesophasenpech zur herstellung von kohlenstoffkoerpern und verfahren zur herstellung derselben. | |
DE69126762D1 (de) | Biologisches Verfahren zur Herstellung von Alpha-Hydroxyamid und Alpha-Hydroxysäure | |
DE68913466T2 (de) | Sputtertarget und Verfahren zu seiner Herstellung. | |
NZ223867A (en) | Platelet-derived growth factor b chain (pdgf b), monoclonal antibodies to it, purification of it using the antibodies, production using genetic engineering and pharmaceuticals | |
DE3680632D1 (de) | Verfahren zur herstellung von kohlenstoffasern und diese kohlenstoffasern. | |
DE3885151D1 (de) | Methode zur Herstellung von Methacrylatestern. | |
DE68917324D1 (de) | Methode zur Immobilisierung von physiologisch aktiven Substanzen. | |
DE69026024T2 (de) | Künstlicher Träger zur Immobilisierung von biologischen Proteinen und Verfahren zu seiner Herstellung | |
DE68926025D1 (de) | Methode zur Herstellung von alpha-Amylase hemmenden Substanzen aus Weizen | |
DE69419639T2 (de) | Verfahren zur Herstellung von Fructose-2,6-diphosphat und Reinigungsverfahren hierfür | |
DE68917642D1 (de) | Verfahren zur kontinuierlichen Züchtung von haftenden tierischen Zellen. | |
PT592685E (pt) | Plantas resistentes a dois ou mais virus e sua preparacao | |
DE69014042T2 (de) | Verfahren zur Herstellung von menschlichem Osteocalcin. | |
FR2619671B1 (fr) | Procede de multiplication et de culture de plantes de la famille des bromeliacees, et plantes ainsi obtenues | |
DE69416015D1 (de) | Verfahren zur Herstellung von Substanzen zur Reinigung von Wasser | |
DE3889441T2 (de) | Katalytisches Verfahren zur Herstellung von optisch aktivem Threonin. | |
DE3883276T2 (de) | Verfahren zur Herstellung von fluorsubstituierten alicyclischen Diolen. | |
DE3887376D1 (de) | 2-Methyl-4-amino-5-aminomethylpyrimidinkarbonat, Verfahren zu dessen Herstellung und diese brauchende Methode zur Reinigung von 2-Methyl-4-amino-5-aminomethylpyrimidin. | |
DE3886121T2 (de) | Verfahren zur Herstellung optischer Fasern und dadurch hergestellte Produkte. | |
DE69224538D1 (de) | Methode zur pyrolyse von organischen materialen | |
ATE15694T1 (de) | Verfahren zur herstellung eines immobilisierten enzymsystems und reinigung von glucose-isomerase. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |